Phio Pharmaceuticals Has Received A Notice Of Allowance For Its Us Patent Application 15/930,377 Titled “Rna Interference In Ocular Indications”
https://patentcenter.uspto.gov/#!/applications/15930377/ifw/docs
Phio Pharmaceuticals Announces Appointment Of Robert Bitterman As Executive Chairman
MARLBOROUGH, Mass., Sept. 29, 2022 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its
Phio Pharmaceuticals Announces Acceptance Of Six Abstracts At The 37th Annual Meeting Of The Society For Immunotherapy Of Cancer
Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today
Phio Pharma’s New Preclinical Data Shows PH-894 Enhances Activity of Cancer CAR-T Cells
Phio Pharmaceuticals Corp (NASDAQ:PHIO) presented new preclinical data showing that silencing BRD4 with PH-894 can improve the quality and potency of…
Phio Pharmaceuticals Q1 EPS $(0.19) Up From $(0.32) YoY
Phio Pharmaceuticals (NASDAQ:PHIO) reported quarterly losses of $(0.19) per share. This is a 40.63 percent increase over losses of $(0.32) per share from the same period last year.
22 Stocks Moving in Friday’s Pre-Market Session
Gainers
Moving iMage Technologies, Inc. (NASDAQ: MITQ) rose 41.7% to $1.63 in pre-market trading. Moving iMage Technologies and SNDBX reported a strategic partnership for gaming and e-Sports.
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers
Hoth Therapeutics (NASDAQ:HOTH) stock rose 156.5% to $1.58 during Monday's pre-market session. The market value of their outstanding shares is at $37.8 million.
Phio Pharma Shares Shine After Positive PH-894 Preclinical Data At AACR Presentation
Phio Pharmaceuticals Corp (NASDAQ: PHIO) has